论文部分内容阅读
目的 观察普米克和博利康尼吸入联合甲基强的松龙治疗毛细支气管炎的临床效果。方法将52例毛细支气管炎患儿随机平均分为两组。治疗组在常规治疗下加用甲基强的松龙1~2 mg/(kg.d)静脉滴注,及普米克0.25~0.5 mg博利康尼2.5 mg雾化吸入2次/d。对照组为常规治疗单加甲基强的松龙1~2 mg/(kg.d),分1~2次静脉滴注。结果治疗组患儿喘息,呼吸困难,并发症的消失及住院时间缩短等方面,与对照组有比较显著差异性,(P<0.001)。结论普米克和博利康尼雾化吸入联合甲基强的松治疗毛细支气管炎可取得满意效果。
Objective To observe the clinical effect of Pulmicort and Boraconi inhalation combined with methylprednisolone in the treatment of bronchiolitis. Methods Fifty-two children with bronchiolitis were randomly divided into two groups. The patients in the treatment group were treated with methylprednisolone 1 ~ 2 mg / (kg.d) intravenously, and pulmicort 0.25 ~ 0.5 mg atomizatin 2.5 mg twice per day for 2 weeks. The control group was treated with methylprednisolone 1 ~ 2 mg / (kg · d). The patients were divided into 1 ~ 2 times intravenous drip. Results There were significant differences between the treatment group and the control group (P <0.001) in wheezing, dyspnea, disappearance of complications and hospitalization time. Conclusion Pulmicort and bleomycin aerosol inhalation combined with methyl prednisone treatment of bronchiolitis can achieve satisfactory results.